CombiMatrix has named Fred Hutchinson Cancer Research Center scientist Muneesh Tewari to its scientific advisory board. Tewari, who is a researcher in The Hutch’s human biology division, has worked at Dana-Farber Cancer Institute, as a physician at Massachusetts General Hospital, and at Brigham and Women’s Hospital at Harvard Medical School.
Strategic Diagnostics has appointed Francis DiNuzzo to serve as president and CEO, and to sit on the company’s board of directors. He was named interim CEO earlier this year.
DiNuzzo formerly was executive VP and chief commercial officer, positions he took on in February. He spent 26 years in the life and analytical sciences industries, and he has served as VP and GM of chemical solutions, consumables and services, and integrated biology solutions at Agilent Technologies.
DxS, a UK-based personalized medicine company, has appointed Stephen Murray as its head of manufacturing at its plant in Manchester. Murray has previously held positions at Axis Shield Diagnostics, and Trinity Biotech.
According to the company, the appointment of Murray is part of an overall manufacturing expansion due to increased demand for its TheraScreen diagnostic test kits, a companion diagnostic to verify patient K-RAS status before treatment with Amgen’s colorectal cancer drug Vectibix.